| Regulating Pair |
| Introduced Variation |
Mutation (protein: R172-172K) of IDH2 |
Protein Info
|
| Induced Change |
2-Hydroxyglutarate concentration: increase |
Metabo Info
|
| Summary |
Introduced Variation
Induced Change
|
|
|
|
|
|
|
|
| Full List of Experiment(s) Validating This Regulating Pair |
| Details of Experiment for Validating This Pair |
[1] |
| Method |
Quantifying the change of 2-hydroxyglutarate concentration after IDH2 mutation (protein: R172-172K) through GC-MS based metabolomics. |
| Disease Status |
Acute myeloid leukaemia |
ICD-11: 2A60 |
| Organ/Tissue/Cell Line |
293T cells (Human embryonic kidney cells) |
Bone Marrow |
| Subcellular Location |
Mitochondrion |
| Tested Species |
Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
|
| Details |
It is reported that mutation (protein with R172-172K) of IDH2 leads to the increase of 2-hydroxyglutarate levels compared with control group in 293T cells. |
|
|
|
|
|
|
|
| References |
| 1 |
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell. 2010 Mar 16;17(3):225-34.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.
